Global Molecular Diagnostics Market Size study, by Product & Services (Reagents & Kits, Instruments, Services & Software), by Technology (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), DNA Microarray, Others), by Application (Infectious Diseases, Oncology, Genetic Tests, Others), by End-User (Hospital & Academic Laboratories, Reference Laboratories, Others) and Regional Forecasts 2020-2026
Global Molecular Diagnostics Market is valued approximately at USD 8.4 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 8.5% over the forecast period 2020-2026. The molecular diagnostics is a technique used to examine biological markers involved in a broad range of human ailments. Molecular diagnostic tests are the basic part of a successful healthcare system. Molecular diagnostic tests deliver vital information that helps healthcare patients and providers to make accurate medical decisions for better outcome of a medical procedure. This technique often provides quantitative measurements that inform each stage of care and facilitate successful management of health circumstances. Molecular diagnostics tools enhance the clinical setting, offer sensitive and rapid approaches for the identification and monitor various infectious diseases such as types of cancer, and other chronic diseases. Thus, rise in the incidences of infectious diseases and cancer owing to growing elderly population, along with the growing awareness and acceptance of personalized medicine and companion diagnostics are the few factors responsible for high CAGR of the market over the forecast period. According to the International Agency for Research on Cancer (IARC), in 2018, there were around 17.0 million new cancer cases and 9.5 million cancer deaths registered throughout the world. Also, the global burden of cancer is expected to grow to almost 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. This, in turn, is expected to accelerate the demand for Molecular Diagnostics, thus contributing to the growth of the global market. However, complex regulatory frameworks delaying the approval of new molecular diagnostic tests are the few factors expected to hamper the growth of the market over the forecast period of 2020-2026.
The regional analysis of global Molecular Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising prevalence of cancer and infectious diseases, presence of a well-developed healthcare infrastructure and rapid rise in clinical laboratories across the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to increased healthcare spending by a larger population base and growing aging population in the countries like China and India.
Major market player included in this report are:
Abbott Laboratories
Becton, Dickinson and Company
Agilent Technologies, Inc.
Biomйrieux Sa
Danaher Corporation
DiaSorin
Grifols, S.A.
Hologic, Inc.
Illumina, Inc.
Thermo Fisher Scientific, Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product & Services:
Reagents & Kits
Instruments
Services & Software
By Technology:
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
DNA Sequencing & Next-Generation Sequencing (NGS)
DNA Microarray
Others
By Application:
Infectious Diseases
Oncology
Genetic Tests
Others
By End-User:
Hospital & Academic Laboratories
Reference Laboratories
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026
Target Audience of the Global Molecular Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
The regional analysis of global Molecular Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising prevalence of cancer and infectious diseases, presence of a well-developed healthcare infrastructure and rapid rise in clinical laboratories across the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026, due to increased healthcare spending by a larger population base and growing aging population in the countries like China and India.
Major market player included in this report are:
Abbott Laboratories
Becton, Dickinson and Company
Agilent Technologies, Inc.
Biomйrieux Sa
Danaher Corporation
DiaSorin
Grifols, S.A.
Hologic, Inc.
Illumina, Inc.
Thermo Fisher Scientific, Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product & Services:
Reagents & Kits
Instruments
Services & Software
By Technology:
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
DNA Sequencing & Next-Generation Sequencing (NGS)
DNA Microarray
Others
By Application:
Infectious Diseases
Oncology
Genetic Tests
Others
By End-User:
Hospital & Academic Laboratories
Reference Laboratories
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017, 2018
Base year – 2019
Forecast period – 2020 to 2026
Target Audience of the Global Molecular Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Molecular Diagnostics Market, by Region, 2018-2026 (USD Billion)
1.2.2. Molecular Diagnostics Market, by Product & Services, 2018-2026 (USD Billion)
1.2.3. Molecular Diagnostics Market, by Technology, 2018-2026 (USD Billion)
1.2.4. Molecular Diagnostics Market, by Application, 2018-2026 (USD Billion)
1.2.5. Molecular Diagnostics Market, by End-User, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL MOLECULAR DIAGNOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL MOLECULAR DIAGNOSTICS MARKET DYNAMICS
3.1. Molecular Diagnostics Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL MOLECULAR DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICES
5.1. Market Snapshot
5.2. Global Molecular Diagnostics Market by Product & Services, Performance - Potential Analysis
5.3. Global Molecular Diagnostics Market Estimates & Forecasts by Product & Services 2016-2026 (USD Billion)
5.4. Molecular Diagnostics Market, Sub Segment Analysis
5.4.1. Reagents & Kits
5.4.2. Instruments
5.4.3. Services & Software
CHAPTER 6. GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. Market Snapshot
6.2. Global Molecular Diagnostics Market by Technology, Performance - Potential Analysis
6.3. Global Molecular Diagnostics Market Estimates & Forecasts by Technology 2016-2026 (USD Billion)
6.4. Molecular Diagnostics Market, Sub Segment Analysis
6.4.1. Polymerase Chain Reaction (PCR)
6.4.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.4.3. DNA Sequencing & Next-Generation Sequencing (NGS)
6.4.4. DNA Microarray
6.4.5. Others
CHAPTER 7. GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Molecular Diagnostics Market by Application, Performance - Potential Analysis
7.3. Global Molecular Diagnostics Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
7.4. Molecular Diagnostics Market, Sub Segment Analysis
7.4.1. Infectious Diseases
7.4.2. Oncology
7.4.3. Genetic Tests
7.4.4. Others
CHAPTER 8. GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global Molecular Diagnostics Market by End-User, Performance - Potential Analysis
8.3. Global Molecular Diagnostics Market Estimates & Forecasts by End-User 2016-2026 (USD Billion)
8.4. Molecular Diagnostics Market, Sub Segment Analysis
8.4.1. Hospital & Academic Laboratories
8.4.2. Reference Laboratories
8.4.3. Others
CHAPTER 9. GLOBAL MOLECULAR DIAGNOSTICS MARKET, REGIONAL ANALYSIS
9.1. Molecular Diagnostics Market, Regional Market Snapshot
9.2. North America Molecular Diagnostics Market
9.2.1. U.S. Molecular Diagnostics Market
9.2.1.1. Product & Services breakdown estimates & forecasts, 2016-2026
9.2.1.2. Technology breakdown estimates & forecasts, 2016-2026
9.2.1.3. Application breakdown estimates & forecasts, 2016-2026
9.2.1.4. End-User breakdown estimates & forecasts, 2016-2026
9.2.2. Canada Molecular Diagnostics Market
9.3. Europe Molecular Diagnostics Market Snapshot
9.3.1. U.K. Molecular Diagnostics Market
9.3.2. Germany Molecular Diagnostics Market
9.3.3. Rest of Europe Molecular Diagnostics Market
9.4. Asia-Pacific Molecular Diagnostics Market Snapshot
9.4.1. China Molecular Diagnostics Market
9.4.2. India Molecular Diagnostics Market
9.4.3. Japan Molecular Diagnostics Market
9.4.4. Rest of Asia Pacific Molecular Diagnostics Market
9.5. Latin America Molecular Diagnostics Market Snapshot
9.5.1. Brazil Molecular Diagnostics Market
9.5.2. Mexico Molecular Diagnostics Market
9.6. Rest of The World Molecular Diagnostics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Abbott Laboratories
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Becton, Dickinson and Company
10.2.3. Agilent Technologies, Inc.
10.2.4. Biomйrieux Sa
10.2.5. Danaher Corporation
10.2.6. DiaSorin
10.2.7. Grifols, S.A.
10.2.8. Hologic, Inc.
10.2.9. Illumina, Inc.
10.2.10. Thermo Fisher Scientific, Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Molecular Diagnostics Market, by Region, 2018-2026 (USD Billion)
1.2.2. Molecular Diagnostics Market, by Product & Services, 2018-2026 (USD Billion)
1.2.3. Molecular Diagnostics Market, by Technology, 2018-2026 (USD Billion)
1.2.4. Molecular Diagnostics Market, by Application, 2018-2026 (USD Billion)
1.2.5. Molecular Diagnostics Market, by End-User, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL MOLECULAR DIAGNOSTICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL MOLECULAR DIAGNOSTICS MARKET DYNAMICS
3.1. Molecular Diagnostics Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
CHAPTER 4. GLOBAL MOLECULAR DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICES
5.1. Market Snapshot
5.2. Global Molecular Diagnostics Market by Product & Services, Performance - Potential Analysis
5.3. Global Molecular Diagnostics Market Estimates & Forecasts by Product & Services 2016-2026 (USD Billion)
5.4. Molecular Diagnostics Market, Sub Segment Analysis
5.4.1. Reagents & Kits
5.4.2. Instruments
5.4.3. Services & Software
CHAPTER 6. GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. Market Snapshot
6.2. Global Molecular Diagnostics Market by Technology, Performance - Potential Analysis
6.3. Global Molecular Diagnostics Market Estimates & Forecasts by Technology 2016-2026 (USD Billion)
6.4. Molecular Diagnostics Market, Sub Segment Analysis
6.4.1. Polymerase Chain Reaction (PCR)
6.4.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.4.3. DNA Sequencing & Next-Generation Sequencing (NGS)
6.4.4. DNA Microarray
6.4.5. Others
CHAPTER 7. GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION
7.1. Market Snapshot
7.2. Global Molecular Diagnostics Market by Application, Performance - Potential Analysis
7.3. Global Molecular Diagnostics Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
7.4. Molecular Diagnostics Market, Sub Segment Analysis
7.4.1. Infectious Diseases
7.4.2. Oncology
7.4.3. Genetic Tests
7.4.4. Others
CHAPTER 8. GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY END-USER
8.1. Market Snapshot
8.2. Global Molecular Diagnostics Market by End-User, Performance - Potential Analysis
8.3. Global Molecular Diagnostics Market Estimates & Forecasts by End-User 2016-2026 (USD Billion)
8.4. Molecular Diagnostics Market, Sub Segment Analysis
8.4.1. Hospital & Academic Laboratories
8.4.2. Reference Laboratories
8.4.3. Others
CHAPTER 9. GLOBAL MOLECULAR DIAGNOSTICS MARKET, REGIONAL ANALYSIS
9.1. Molecular Diagnostics Market, Regional Market Snapshot
9.2. North America Molecular Diagnostics Market
9.2.1. U.S. Molecular Diagnostics Market
9.2.1.1. Product & Services breakdown estimates & forecasts, 2016-2026
9.2.1.2. Technology breakdown estimates & forecasts, 2016-2026
9.2.1.3. Application breakdown estimates & forecasts, 2016-2026
9.2.1.4. End-User breakdown estimates & forecasts, 2016-2026
9.2.2. Canada Molecular Diagnostics Market
9.3. Europe Molecular Diagnostics Market Snapshot
9.3.1. U.K. Molecular Diagnostics Market
9.3.2. Germany Molecular Diagnostics Market
9.3.3. Rest of Europe Molecular Diagnostics Market
9.4. Asia-Pacific Molecular Diagnostics Market Snapshot
9.4.1. China Molecular Diagnostics Market
9.4.2. India Molecular Diagnostics Market
9.4.3. Japan Molecular Diagnostics Market
9.4.4. Rest of Asia Pacific Molecular Diagnostics Market
9.5. Latin America Molecular Diagnostics Market Snapshot
9.5.1. Brazil Molecular Diagnostics Market
9.5.2. Mexico Molecular Diagnostics Market
9.6. Rest of The World Molecular Diagnostics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Abbott Laboratories
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Becton, Dickinson and Company
10.2.3. Agilent Technologies, Inc.
10.2.4. Biomйrieux Sa
10.2.5. Danaher Corporation
10.2.6. DiaSorin
10.2.7. Grifols, S.A.
10.2.8. Hologic, Inc.
10.2.9. Illumina, Inc.
10.2.10. Thermo Fisher Scientific, Inc.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL MOLECULAR DIAGNOSTICS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL MOLECULAR DIAGNOSTICS MARKET
TABLE 3. GLOBAL MOLECULAR DIAGNOSTICS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY PRODUCT & SERVICES 2016-2026 (USD BILLION)
TABLE 8. GLOBAL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD BILLION)
TABLE 9. GLOBAL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
TABLE 10. GLOBAL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD BILLION)
TABLE 11. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. U.S. MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 22. U.S. MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 23. U.S. MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 24. CANADA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 25. CANADA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 26. CANADA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 27. UK MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 28. UK MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 29. UK MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. GERMANY MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 31. GERMANY MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 32. GERMANY MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. ROE MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 34. ROE MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 35. ROE MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. CHINA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 37. CHINA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 38. CHINA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. INDIA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 40. INDIA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 41. INDIA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. JAPAN MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 43. JAPAN MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 44. JAPAN MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. ROAPAC MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 46. ROAPAC MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 47. ROAPAC MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. BRAZIL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 49. BRAZIL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50. BRAZIL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. MEXICO MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 52. MEXICO MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 53. MEXICO MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. ROLA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 55. ROLA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 56. ROLA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. ROW MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 58. ROW MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 59. ROW MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL MOLECULAR DIAGNOSTICS MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL MOLECULAR DIAGNOSTICS MARKET
TABLE 3. GLOBAL MOLECULAR DIAGNOSTICS MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. GLOBAL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY PRODUCT & SERVICES 2016-2026 (USD BILLION)
TABLE 8. GLOBAL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY TECHNOLOGY 2016-2026 (USD BILLION)
TABLE 9. GLOBAL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
TABLE 10. GLOBAL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD BILLION)
TABLE 11. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 21. U.S. MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 22. U.S. MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 23. U.S. MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 24. CANADA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 25. CANADA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 26. CANADA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 27. UK MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 28. UK MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 29. UK MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. GERMANY MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 31. GERMANY MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 32. GERMANY MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. ROE MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 34. ROE MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 35. ROE MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. CHINA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 37. CHINA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 38. CHINA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. INDIA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 40. INDIA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 41. INDIA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. JAPAN MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 43. JAPAN MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 44. JAPAN MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. ROAPAC MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 46. ROAPAC MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 47. ROAPAC MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. BRAZIL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 49. BRAZIL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50. BRAZIL MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. MEXICO MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 52. MEXICO MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 53. MEXICO MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. ROLA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 55. ROLA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 56. ROLA MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. ROW MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 58. ROW MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 59. ROW MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
LIST OF FIGURES
FIG 1. GLOBAL MOLECULAR DIAGNOSTICS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL MOLECULAR DIAGNOSTICS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL MOLECULAR DIAGNOSTICS MARKET, KEY TRENDS 2019
FIG 5. GLOBAL MOLECULAR DIAGNOSTICS MARKET, GROWTH PROSPECTS 2020-2026
FIG 6. GLOBAL MOLECULAR DIAGNOSTICS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL MOLECULAR DIAGNOSTICS MARKET, PEST ANALYSIS
FIG 8. GLOBAL MOLECULAR DIAGNOSTICS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. GLOBAL MOLECULAR DIAGNOSTICS MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 16. EUROPE MOLECULAR DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 17. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 18. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 19. GLOBAL MOLECULAR DIAGNOSTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)
COMPANIES MENTIONED
Abbott Laboratories
Becton, Dickinson and Company
Agilent Technologies, Inc.
Biomйrieux Sa
Danaher Corporation
DiaSorin
Grifols, S.A.
Hologic, Inc.
Illumina, Inc.
Thermo Fisher Scientific, Inc.
FIG 1. GLOBAL MOLECULAR DIAGNOSTICS MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL MOLECULAR DIAGNOSTICS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL MOLECULAR DIAGNOSTICS MARKET, KEY TRENDS 2019
FIG 5. GLOBAL MOLECULAR DIAGNOSTICS MARKET, GROWTH PROSPECTS 2020-2026
FIG 6. GLOBAL MOLECULAR DIAGNOSTICS MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL MOLECULAR DIAGNOSTICS MARKET, PEST ANALYSIS
FIG 8. GLOBAL MOLECULAR DIAGNOSTICS MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. GLOBAL MOLECULAR DIAGNOSTICS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. GLOBAL MOLECULAR DIAGNOSTICS MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 16. EUROPE MOLECULAR DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 17. ASIA PACIFIC MOLECULAR DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 18. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET 2016 & 2026 (USD BILLION)
FIG 19. GLOBAL MOLECULAR DIAGNOSTICS MARKET, COMPANY MARKET SHARE ANALYSIS (2019)
COMPANIES MENTIONED
Abbott Laboratories
Becton, Dickinson and Company
Agilent Technologies, Inc.
Biomйrieux Sa
Danaher Corporation
DiaSorin
Grifols, S.A.
Hologic, Inc.
Illumina, Inc.
Thermo Fisher Scientific, Inc.
